These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23191943)

  • 1. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials.
    Riaz IB; Riaz H; Riaz T; Rahman S; Amir M; Badshah MB; Kazi AN
    BMC Gastroenterol; 2012 Nov; 12():170. PubMed ID: 23191943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin analogues in chemoprevention of hepatocellular carcinoma after resection or ablation--a systematic review and meta-analysis.
    Chu KJ; Lai EC; Yao XP; Zhang HW; Lau WY; Fu XH; Lu CD; Shi J; Cheng SQ
    Asian J Surg; 2010 Jul; 33(3):120-6. PubMed ID: 21163409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.
    Yoshida H; Shiratori Y; Kudo M; Shiina S; Mizuta T; Kojiro M; Yamamoto K; Koike Y; Saito K; Koyanagi N; Kawabe T; Kawazoe S; Kobashi H; Kasugai H; Osaki Y; Araki Y; Izumi N; Oka H; Tsuji K; Toyota J; Seki T; Osawa T; Masaki N; Ichinose M; Seike M; Ishikawa A; Ueno Y; Tagawa K; Kuromatsu R; Sakisaka S; Ikeda H; Kuroda H; Kokuryu H; Yamashita T; Sakaida I; Katamoto T; Kikuchi K; Nomoto M; Omata M
    Hepatology; 2011 Aug; 54(2):532-40. PubMed ID: 21574174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study.
    Mizuta T; Ozaki I; Eguchi Y; Yasutake T; Kawazoe S; Fujimoto K; Yamamoto K
    Cancer; 2006 Feb; 106(4):867-72. PubMed ID: 16400650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative use of the chemopreventive vitamin K2 analog in patients with hepatocellular carcinoma.
    Zhong JH; Mo XS; Xiang BD; Yuan WP; Jiang JF; Xie GS; Li LQ
    PLoS One; 2013; 8(3):e58082. PubMed ID: 23505456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials.
    Zhong JH; Li H; Li LQ; You XM; Zhang Y; Zhao YN; Liu JY; Xiang BD; Wu GB
    Eur J Surg Oncol; 2012 Apr; 38(4):286-95. PubMed ID: 22281155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection.
    Kakizaki S; Sohara N; Sato K; Suzuki H; Yanagisawa M; Nakajima H; Takagi H; Naganuma A; Otsuka T; Takahashi H; Hamada T; Mori M
    J Gastroenterol Hepatol; 2007 Apr; 22(4):518-22. PubMed ID: 17376044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW
    Osteoporos Int; 2015 Mar; 26(3):1175-86. PubMed ID: 25516361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of menatetrenone, a vitamin k2 analog, on recurrence of hepatocellular carcinoma after surgical resection: a prospective randomized controlled trial.
    Ishizuka M; Kubota K; Shimoda M; Kita J; Kato M; Park KH; Shiraki T
    Anticancer Res; 2012 Dec; 32(12):5415-20. PubMed ID: 23225445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
    Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
    Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma and vitamin K.
    Mizuta T; Ozaki I
    Vitam Horm; 2008; 78():435-42. PubMed ID: 18374204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Zhang CH; Xu GL; Jia WD; Ge YS
    Int J Cancer; 2009 Jun; 124(12):2982-8. PubMed ID: 19296539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.
    Samuel M; Chow PK; Chan Shih-Yen E; Machin D; Soo KC
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD001199. PubMed ID: 19160192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Schoppmeyer K; Weis S; Mössner J; Fleig WE
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006745. PubMed ID: 19588401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.
    Khajeh E; Moghadam AD; Eslami P; Ali-Hasan-Al-Saegh S; Ramouz A; Shafiei S; Ghamarnejad O; Dezfouli SA; Rupp C; Springfeld C; Carvalho C; Probst P; Mousavizadeh SM; Mehrabi A
    BMC Cancer; 2022 Jan; 22(1):91. PubMed ID: 35062904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
    Stevenson M; Lloyd-Jones M; Papaioannou D
    Health Technol Assess; 2009 Sep; 13(45):iii-xi, 1-134. PubMed ID: 19818211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.
    Habu D; Shiomi S; Tamori A; Takeda T; Tanaka T; Kubo S; Nishiguchi S
    JAMA; 2004 Jul; 292(3):358-61. PubMed ID: 15265851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin K2 on the recurrence in patients with hepatocellular carcinoma.
    Hotta N; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Ohashi T; Kakumu S
    Hepatogastroenterology; 2007; 54(79):2073-7. PubMed ID: 18251162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of adjuvant i(131) lipiodol after excision of hepatocellular carcinoma.
    Furtado R; Crawford M; Sandroussi C
    Ann Surg Oncol; 2014 Aug; 21(8):2700-7. PubMed ID: 24743904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; Caron HN; van Dalen EC
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.